Relationship of inhaled long-acting bronchodilators with cardiovascular outcomes among patients with stable COPD: a meta-analysis and systematic review of 43 randomized trials

Background: Long-acting muscarinic antagonists (LAMAs) and long-acting β2–agonists (LABAs) are the mainstay of maintenance therapy for chronic obstructive pulmonary disease (COPD). Although previous studies have supported inhaled long-acting bronchodilators (ILABs) for overall cardiovascular safety,...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chenxi, Cheng, Wenke, Guo, Jin, Guan, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489598/
https://www.ncbi.nlm.nih.gov/pubmed/31114181
http://dx.doi.org/10.2147/COPD.S198288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489598/
https://www.ncbi.nlm.nih.gov/pubmed/31114181
http://dx.doi.org/10.2147/COPD.S198288

Ejemplares similares